ProShares UltraShort Nasdaq BiotechnologyBIS
Type
ETF
Peer group
Alternative
Net assets
$2.4M
Expense ratio
0.95%
1-year return
-59.2%
3 years, a year
-32.7%
5 years, a year
-17.6%
12-month yield
5.51%
Holdings
14
What it aims to do.
ProShares UltraShort Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index (the Index).
Top 10 holdings.
| Holding | % of fund |
|---|---|
| JOBY Repurchase Agreement | 32.76% |
| JOBY Repurchase Agreement | 16.24% |
| JOBY Repurchase Agreement | 16.24% |
| JOBY Repurchase Agreement | 9.74% |
| JOBY Repurchase Agreement | 9.74% |
| JOBY Repurchase Agreement | 8.12% |
| JOBY Repurchase Agreement | 6.49% |
| JOBY Repurchase Agreement | 6.49% |
| JOBY Repurchase Agreement | 3.25% |
| N/A | -3.45% |
More on BIS.
- BIS overview
- BIS holdings
- BIS risk
- BIS costs
- BIS money in and out
- BIS share classes
- Compare BIS with other funds
Returns after fees, from the fund's SEC filings up to Aug 2026. Past returns are not a promise. Not financial advice.